Načítá se...
Efficacy of XELOX plus Bevacizumab in Brain Metastasis from Rectal Cancer
Brain metastasis (BM) is rare in colorectal cancer (CRC) patients. Although BM from CRC is a late-stage phenomenon with an extremely poor prognosis, some subsets of patients would benefit from a multidisciplinary management strategy. The prognosis of patients with BM from CRC was associated with the...
Uloženo v:
Hlavní autoři: | , , , , , , , |
---|---|
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
S. Karger AG
2014
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3975757/ https://ncbi.nlm.nih.gov/pubmed/24707258 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000360132 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|